2009 Issues December 2009 Issue • Feature - No Vacancy* • Editor's Note • New Drugs of 2007 • Index for Volume 1, 2006 • Index for Volume 2, 2007 November 2009 Issue • Feature - What are they Doing to our Profession? - And Who Cares? • New Drug Review - Dronedarone (Multaq - Sanofi-Aventis) October 2009 Issue • Feature - The Influenza Follies • New Drug Review - Saxagliptin hydrochloride (Onglyza - Bristol-Myers Squibb; AstraZeneca) September 2009 Issue • Feature - Prescription Benefit Programs - Classes of Pharmacies Should be Established • New Drug Review - Prasugrel hydrochloride (Effient - Daiichi Sankyo; Lilly) Antiplatelet Agent August 2009 Issue • Feature - Addiction Pharmacy Should Assume a Leadership Role in Addressing this Devastating Problem! • New Drug Review - Tapentadol hydrochloride (Nucynta - PriCara) Analgesic July 2009 Issue • Feature - The Acetaminophen Challenge (and Recommendations) • New Drug Review - Lacosamide (Vimpat - UCB) June 2009 Issue • Feature - Prescription Benefit Programs - A New Model IS Needed! • New Drug Review - Besifloxacin hydrochloride (Besivance - Bausch & Lomb) May 2009 Issue • Feature - CVS Caremark - An Alliance that Must be Broken • New Drug Review - Golimumab (Simponi - Centocor Ortho Biotech) April 2009 Issue • Feature - Dear Legislator • New Drug Review - Febuxostat (Uloric - Takeda) March 2009 Issue • Feature - Coupons, $4 generics, and Free Generic Antibiotics - Disservices to Patients and Insults to Pharmacists • New Drug Review - Silodosin (Rapaflo - Watson) February 2009 Issue • Feature - Pfizer Should Not be Permitted to Acquire Wyeth! • New Drug Review - Milnacipran hydrochloride (Savella - Forest; Cypress) January 2009 Issue • Feature - A New Year, an Old Theme Can our National Pharmacy Associations Reach Nome? • New Drug Review - Fesoterodine fumarate (Toviaz - Pfizer) |
